FindTrial
Sign In

A Study on Predicting Multiplex Immunofluorescence Expression and Clinical Prognosis in Colorectal Cancer Using Pathological Images and Large-Scale Models

A Study on Predicting Multiplex Immunofluorescence Expression and Clinical Prognosis in Colorectal Cancer Using Pathological Images and Large-Scale Models

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500100445
Enrollment
Unknown
Registered
2025-04-09
Start date
2025-04-14
Completion date
Unknown
Last updated
2025-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal Cancer

Interventions

Colorectal adenocarcinoma case group:None

Sponsors

Chengdu Shangjin Nanfu Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Pathologic diagnosis of colorectal adenocarcinoma; 2. Clinical/pathological stage of 1/2/3; 3. Radical surgery; 4. Follow-up for 3 years or more.

Exclusion criteria

Exclusion criteria: 1. Neoadjuvant therapy; 2. Loss to follow-up.

Design outcomes

Primary

MeasureTime frame
Disease-specific survival;—

Countries

China

Contacts

Public ContactDan Jiang

Department of Pathology, West China Hospital, Sichuan University;Department of Pathology, Chengdu Shangjin Nanfu Hospital

danjiang@scu.edu.cn+86 28 8542 2701

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026